General Information of Drug (ID: DM0Y5NU)

Drug Name
PMID27539678-Compound-9 Drug Info
Cross-matching ID
PubChem CID
72735440
TTD Drug ID
DM0Y5NU

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Phenoxodiol DMBUJVX Ovarian cancer 2C73 Phase 1/2 [2]
GSK618334 DMJPXZ4 Drug abuse 6C4G.1Z Phase 1 [3]
PMID27539678-Compound-6 DMBKNDE N. A. N. A. Patented [1]
Methylbenzenesulfonamide derivative 1 DMUNME2 N. A. N. A. Patented [1]
PMID27539678-Compound-12 DMNIKTA N. A. N. A. Patented [1]
PMID27539678-Compound-10 DM61SR0 N. A. N. A. Patented [1]
PMID27539678-Compound-16 DMMDJH8 N. A. N. A. Patented [1]
PMID27539678-Compound-14 DMZ02LA N. A. N. A. Patented [1]
PMID27539678-Compound-13 DM1J2V8 N. A. N. A. Patented [1]
PMID27539678-Compound-11 DMIKAJC N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Sphingosine kinase 1 (SPHK1) TTOHFIY SPHK1_HUMAN Inhibitor [1]

References

1 Sphingosine kinase inhibitors: a review of patent literature (2006-2015).Expert Opin Ther Pat. 2016 Dec;26(12):1409-1416.
2 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
3 Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.Oncotarget. 2016 Dec 6;7(49):80586-80598.